Dexrazoxane Market Size, Regional Status and Outlook 2026-2035
The dexrazoxane market was valued at USD 887.7 million in 2025 and is projected to reach USD 1,502 million by 2035, growing at a CAGR of 5.4% during the forecast period (2026–2035). The market’s growth is driven by the increasing use of dexrazoxane in oncology for preventing cardiotoxicity caused by anthracycline-based chemotherapy, especially in patients with breast cancer, leukemia, and lymphoma.